APIs para pesquisa e impurezas

<p>Please enquire for more information about 2-Desmethylene-2-chloromethyl ethacrynic acid including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

<p>10-{3-[4-(2-Chloro-ethyl)-piperazin-1-yl]-propyl}-2-trifluoromethyl-10H-phenothiazine is a nonselective, competitive antagonist of glutamate and quinpirole. It has been shown to block the glutamate receptors in the brain and reduce dopamine release. 10-[3-[4-(2-Chloro-ethyl)-piperazin-1-yl]-propyl]-2-trifluoromethylphenothiazine has a high affinity for the ryanodine receptor, which is found in the sarcoplasmic reticulum of striatal neurons. This drug also binds to calmodulin with high affinity, which may account for its ability to inhibit covalent adducts of dopamine to proteins. 10-[3-[4-(2-Chloro-ethyl)-piperazin-1-yl</p>

<p>Pemetrexed is an antifolate drug that is used to treat cancer. It is a prodrug of pemetrexed disodium, which is converted to pemetrexed in the body by esterases. Pemetrexed is metabolized to its active form, D-pemetrexed, which inhibits DNA synthesis and the growth of cells by inhibiting thymidylate synthase. D-Pemetrexed hydrate is a high purity, pharmacopoeia grade impurity standard for use in research and development or as a custom synthesis. It has been shown to inhibit the growth of certain types of cancer cells and can be used in combination with other treatments such as chemotherapy or radiation therapy.</p>

<p>Benquinox is a potent inhibitor of protein kinases that has shown promise in the treatment of cancer. It works by blocking the activity of certain kinases that are involved in cell growth and division, leading to apoptosis (programmed cell death) in cancer cells. Benquinox is an analog of donepezil, a drug used to treat Alzheimer's disease. Studies have shown that Benquinox inhibits tumor growth and induces apoptosis in human cancer cell lines. It has also been found to be effective against urinary tract tumors in Chinese patients. As an anticancer agent, Benquinox is being investigated for its potential use as a targeted therapy for various types of cancer. Its ability to inhibit kinases makes it a promising candidate for combination therapies with other kinase inhibitors.</p>